We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


TB Alliance and BioFocus Sign Compound Management Agreement

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
BioFocus announced that it has signed a three year compound management agreement with the Global Alliance for TB Drug Development (TB Alliance).

Under this agreement BioFocus will manage TB Alliance’s chemical library collection. These services will be provided by BioFocus’ compound management facility in South San Francisco, USA.

“We are pleased to welcome TB Alliance as a new client to our compound management services, joining other prestigious names such as the National Institutes of Health,” said Scott Snyder, BioFocus’ Senior Director, Compound Management. “This collaboration leverages our full suite of compound management services and further expands our client base of not-for-profit discovery organizations to a global level.”